Eizen Joshua M
Insider CIK 1949621 · ANTX See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANTX AN2 Therapeutics, Inc. | S Sale | 2026-07-08 | 2026-07-10 | 5,945 | $4.17 | $24.8K | 206,554 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 50,150 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 50,150 | — | $0 | 50,150 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | D To issuer deriv | 2026-03-19 | 2026-03-23 | 92,000 | — | $0 | 0 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-03-19 | 2026-03-23 | 92,000 | — | $0 | 92,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2026-02-20 | 2026-02-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2026-02-20 | 2026-02-23 | 50,000 | — | $0 | 207,499 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2026-01-06 | 2026-01-07 | 6,931 | $1.01 | $7.0K | 152,499 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-07 | 17,923 | $1.00 | $17.9K | 159,430 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2025-11-04 | 2025-11-06 | 2,819 | $1.14 | $3.2K | 177,353 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2025-02-26 | 2025-02-28 | 117,000 | — | $0 | 117,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2025-02-26 | 2025-02-28 | 58,500 | — | $0 | 175,172 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | S Sale | 2025-01-03 | 2025-01-07 | 9,663 | $1.34 | $12.9K | 116,672 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-11-04 | 2024-11-05 | 63,000 | — | $0 | 63,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-11-04 | 2024-11-05 | 31,500 | — | $0 | 126,335 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-07-10 | 2024-07-12 | 60,000 | — | $0 | 94,833 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2024-03-15 | 2024-03-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-03-15 | 2024-03-18 | 30,000 | — | $0 | 32,447 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award | 2024-03-15 | 2024-03-29 | 30,000 | — | $0 | 32,447 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2023-02-15 | 2023-02-17 | 50,150 | — | $0 | 50,150 | SEC↗ |
| ANTX AN2 Therapeutics, Inc. | A Award deriv | 2022-10-14 | 2022-10-28 | 92,000 | — | $0 | 92,000 | SEC↗ |